Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population-Reference-Cited by-同舟云学术

Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population

Published:2022-10-17 Issue:1 Volume:110 Page:67-76
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Graf Irene¹²^ORCID,Herndlhofer Susanne¹²,Kundi Michael³,Greiner Georg⁴,Sperr Martina¹,Hadzijusufovic Emir¹²,Valent Peter¹²,Sperr Wolfgang R.¹²

Affiliation:

1. Division of Hematology and Hemostaseology, Department of Internal Medicine I Medical University of Vienna Vienna Austria

2. Ludwig Boltzmann Institute of Hematology and Oncology Medical University of Vienna Vienna Austria

3. Institute of Environmental Health Medical University of Vienna Vienna Austria

4. Ihr Labor, Medical Diagnostic Laboratories Vienna Austria

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13875

Reference57 articles.

1. The Novel Coronavirus Originating in Wuhan, China

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

3. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

5. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies to type I interferons in patients with systemic mastocytosis;Journal of Allergy and Clinical Immunology: Global;2024-08

2. Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era;Annals of Hematology;2023-08-14

3. COVID-19 Impact on Chronic Myeloid Leukemia Patients;Journal of Personalized Medicine;2022-11-10